Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing-Reference-Cited by-同舟云学术

Decoding variants in drug-metabolizing enzymes and transporters in solid tumor patients by whole-exome sequencing

Published:2021-01 Issue:1 Volume:28 Page:628-634
ISSN:1319-562X
Container-title:Saudi Journal of Biological Sciences
language:en
Short-container-title:Saudi Journal of Biological Sciences

Author:

Aboul-Soud Mourad A.M.,Alzahrani Alhussain J.,Mahmoud Amer

Funder

National Plan for Science,Technology and Innovation

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences

Reference32 articles.

1. Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity;Amstutz;Pharmacogenomics,2011

2. Clinical pharmacogenetics implementation consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update;Amstutz;Clin. Pharmacol. Therapeut.,2018

3. Assessment of thiopurine-based drugs according to thiopurine S-methyltransferase genotype in patients with acute lymphoblastic leukemia;Azimi;Iran J. Ped. Hematol. Oncol.,2014

4. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs;Bertilsson;Br. J Clin. Pharmacol.,2002

5. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man;Bosma;J. Biol. Chem.,1994

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-Based Technologies in Cancer Therapy;Journal of Personalized Medicine;2023-11-09

2. A novel nonsense variant in the ATL3 gene is associated with disturbed pain sensitivity, numbness of distal limbs and muscle weakness;Annals of Human Genetics;2023-03

3. The Use of Next-Generation Sequencing in Pharmacogenomics;Clinical Laboratory;2023

4. Introducing a simple and cost-effective RT-PCR protocol for detection of DPYD*2A polymorphism: the first study in Kurdish population;Cancer Chemotherapy and Pharmacology;2022-09-09

5. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard;Saudi Pharmaceutical Journal;2022-08